The overall tone reflects positive reception, with many emphasizing the guideline's focus on shared decision-making and patient-centered treatments, as seen in comments about personalized care and references to the full article, demonstrating both high interest and meaningful engagement.
AgreementModerate agreement
Most discussions express support or positive recognition of the guideline, acknowledging its focus on personalized care and shared decision-making.
InterestHigh interest
The posts indicate high curiosity and engagement, with many participants highlighting the importance and relevance of the guideline.
EngagementModerate engagement
Several posts reference specific aspects such as shared decision-making, personalized treatment, and the impact on clinical practice, showing thoughtful engagement.
ImpactModerate impact
The discussions suggest the guideline could influence clinical approaches and policy, highlighting its potential significance in urological practice.
Abstract in brief
The AUASUFU Guideline aims to help healthcare providers evaluate and treat idiopathic overactive bladder (OAB) by offering evidence-based recommendations, focusing on accurate diagnosis, personalized treatment choices, and improving patient quality of life while reducing side effects.
The guideline is based on a systematic review of 159 studies from 2013 to 2023, which informed 33 specific statements about diagnosing OAB, various treatment options including noninvasive, pharmacologic, minimally invasive, invasive therapies, and managing OAB in patients with BPH.
Once OAB is diagnosed, doctors and patients should collaborate through shared decision-making to select personalized treatments that align with the best available evidence and patient preferences, aiming to optimize symptom control and minimize disease burden.
Dec 27, 2024 · 78 likes · 14 shares · 6,405 followersView post →
CC
Confederación Americana de Urología (CAU)
@CAU_URO · X
#JournalClubCAU
EDICION NOVIEMBRE 2024
Nov 16, 2024 · 19 likes · 5 shares · 7,420 followersView post →
MU
Mayo Clinic Urology
@MayoUrology · X
Check out the new AUA/SUFU guideline (2024) on the diagnosis and treatment of OAB, focused on shared decision-making and a personalized approach to care.
#AUA24 @sufuorg @amerurological @brianjlinder
https://t.co/A9Drp3BBZy
This video reviews the AUA/SUFU guidelines for diagnosing and treating idiopathic overactive bladder, emphasizing evidence-based recommendations, personalized treatment, and recent advancements in minimally invasive…
Check out the new AUA/SUFU guideline (2024) on the diagnosis and treatment of OAB, focused on shared decision-making and a personalized approach to care.
#AUA24 @sufuorg @amerurological @brianjlinder
https://t.co/A9Drp3BBZy